Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Michael Tuttle

Showing results (171-180 of 320) with videos related to

Pageof 32
Sort By:
Clinical Endocrinology|January 18, 2012
Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapyFernanda Vaisman, Denise Momesso, Daniel A Bulzico, et al.
Thyroid : Official Journal of the American Thyroid Association|July 29, 2014
The 2009 American Thyroid Association guidelines modestly reduced radioactive iodine use for thyroid cancers less than 1 cmBenjamin R Roman, Jordyn H Feingold, Snehal G Patel, et al.
Thyroid : Official Journal of the American Thyroid Association|April 5, 2012
Papillary thyroid carcinomas with cervical lymph node metastases can be stratified into clinically relevant prognostic categories using oncogenic BRAF, the number of nodal metastases, and extra-nodal extensionJulio Ricarte-Filho, Ian Ganly, Michael Rivera, et al.
Thyroid : Official Journal of the American Thyroid Association|January 8, 2020
Management of Retropharyngeal Lymph Node Metastases in Differentiated Thyroid CarcinomaVictoria Harries, Marlena McGill, R Michael Tuttle, et al.
Thyroid : Official Journal of the American Thyroid Association|November 23, 2013
Prognostic implications of papillary thyroid carcinoma with tall-cell featuresIan Ganly, Tihana Ibrahimpasic, Michael Rivera, et al.
Archives of Otolaryngology--Head & Neck Surgery|February 14, 2013
Selective use of radioactive iodine in intermediate-risk papillary thyroid cancerIain J Nixon, Snehal G Patel, Frank L Palmer, et al.
Annals of Surgical Oncology|November 5, 2014
Postoperative Nomogram for Predicting Cancer-Specific Mortality in Medullary Thyroid CancerAllen S Ho, Lu Wang, Frank L Palmer, et al.
Thyroid : Official Journal of the American Thyroid Association|November 2, 2010
Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging systemR Michael Tuttle, Hernan Tala, Jatin Shah, et al.
Cancer|February 14, 2006
Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patientsDavid Hiltzik, Diane L Carlson, R Michael Tuttle, et al.
Thyroid : Official Journal of the American Thyroid Association|August 12, 2008
ret/PTC activation is not associated with individual radiation dose estimates in a pilot study of neoplastic thyroid nodules arising in Russian children and adults exposed to Chernobyl falloutR Michael Tuttle, Yvonne Lukes, Lynn Onstad, et al.
Pageof 32

Showing results (171-180 of 320) with videos related to

Sort By:
Pageof 32
Clinical Endocrinology|January 18, 2012
Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapyFernanda Vaisman, Denise Momesso, Daniel A Bulzico, et al.
Thyroid : Official Journal of the American Thyroid Association|July 29, 2014
The 2009 American Thyroid Association guidelines modestly reduced radioactive iodine use for thyroid cancers less than 1 cmBenjamin R Roman, Jordyn H Feingold, Snehal G Patel, et al.
Thyroid : Official Journal of the American Thyroid Association|April 5, 2012
Papillary thyroid carcinomas with cervical lymph node metastases can be stratified into clinically relevant prognostic categories using oncogenic BRAF, the number of nodal metastases, and extra-nodal extensionJulio Ricarte-Filho, Ian Ganly, Michael Rivera, et al.
Thyroid : Official Journal of the American Thyroid Association|January 8, 2020
Management of Retropharyngeal Lymph Node Metastases in Differentiated Thyroid CarcinomaVictoria Harries, Marlena McGill, R Michael Tuttle, et al.
Thyroid : Official Journal of the American Thyroid Association|November 23, 2013
Prognostic implications of papillary thyroid carcinoma with tall-cell featuresIan Ganly, Tihana Ibrahimpasic, Michael Rivera, et al.
Archives of Otolaryngology--Head & Neck Surgery|February 14, 2013
Selective use of radioactive iodine in intermediate-risk papillary thyroid cancerIain J Nixon, Snehal G Patel, Frank L Palmer, et al.
Annals of Surgical Oncology|November 5, 2014
Postoperative Nomogram for Predicting Cancer-Specific Mortality in Medullary Thyroid CancerAllen S Ho, Lu Wang, Frank L Palmer, et al.
Thyroid : Official Journal of the American Thyroid Association|November 2, 2010
Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging systemR Michael Tuttle, Hernan Tala, Jatin Shah, et al.
Cancer|February 14, 2006
Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patientsDavid Hiltzik, Diane L Carlson, R Michael Tuttle, et al.
Thyroid : Official Journal of the American Thyroid Association|August 12, 2008
ret/PTC activation is not associated with individual radiation dose estimates in a pilot study of neoplastic thyroid nodules arising in Russian children and adults exposed to Chernobyl falloutR Michael Tuttle, Yvonne Lukes, Lynn Onstad, et al.
Pageof 32